Skip to main content
Erschienen in: Strahlentherapie und Onkologie 11/2015

01.11.2015 | Original Article

Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer

A comparison between two modalities

verfasst von: Tiina Seppälä, Ph.D., Harri Visapää, M.D., Juhani Collan, M.D., Mika Kapanen, Ph.D., Annette Beule, M.D., Mauri Kouri, M.D., Mikko Tenhunen, Ph.D., Kauko Saarilahti, M.D.

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the conversion of prostate cancer radiotherapy (RT) target definition from CT-based planning into an MRI-only-based planning procedure.

Materials and methods

Using the CT- and MRI-only-based RT planning protocols, 30 prostate cancer patients were imaged in the RT fixation position. Two physicians delineated the prostate in both CT and T2-weighted MRI images. The CT and MRI images were coregistered based on gold seeds and anatomic borders of the prostate. The uncertainty of the coregistration, as well as differences in target volumes and uncertainty of contour delineation were investigated. Conversion of margins and dose constraints from CT- to MRI-only-based treatment planning was assessed.

Results

On average, the uncertainty of image coregistration was 0.4 ± 0.5 mm (one standard deviation, SD), 0.9 ± 0.8 mm and 0.9 ± 0.9 mm in the lateral, anterior–posterior and base–apex direction, respectively. The average ratio of the prostate volume between CT and MRI was 1.20 ± 0.15 (one SD). Compared to the CT-based contours, the MRI-based contours were on average 2–7 mm smaller in the apex, 0–1 mm smaller in the rectal direction and 1–4 mm smaller elsewhere.

Conclusion

When converting from a CT-based planning procedure to an MRI-based one, the overall planning target volumes (PTV) are prominently reduced only in the apex. The prostate margins and dose constraints can be retained by this conversion.
Literatur
1.
Zurück zum Zitat Chen Z, Ma CM, Paskalev K et al (2006) Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. Phys Med Biol 51:1393–1403CrossRefPubMed Chen Z, Ma CM, Paskalev K et al (2006) Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. Phys Med Biol 51:1393–1403CrossRefPubMed
2.
Zurück zum Zitat Kapanen M, Collan J, Beule A et al (2013) Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate. Magn Reson Med 70:127–135CrossRefPubMed Kapanen M, Collan J, Beule A et al (2013) Commissioning of MRI-only based treatment planning procedure for external beam radiotherapy of prostate. Magn Reson Med 70:127–135CrossRefPubMed
3.
Zurück zum Zitat Korhonen J, Kapanen M, Keyriläinen J et al (2014) Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients. Acta Oncol 53:1100–1106CrossRefPubMed Korhonen J, Kapanen M, Keyriläinen J et al (2014) Influence of MRI-based bone outline definition errors on external radiotherapy dose calculation accuracy in heterogeneous pseudo-CT images of prostate cancer patients. Acta Oncol 53:1100–1106CrossRefPubMed
4.
Zurück zum Zitat Lee YK, Bollet M, Charles-Edwards G et al (2003) Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiother Oncol 66:203–216CrossRefPubMed Lee YK, Bollet M, Charles-Edwards G et al (2003) Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiother Oncol 66:203–216CrossRefPubMed
5.
Zurück zum Zitat Chen L, Price RA, Nguyen T-B et al (2004) Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Phys Med Biol 49:5157–5170CrossRefPubMed Chen L, Price RA, Nguyen T-B et al (2004) Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Phys Med Biol 49:5157–5170CrossRefPubMed
6.
Zurück zum Zitat Chen L, Price RA, Wang L et al (2004) MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys 60:636–647CrossRefPubMed Chen L, Price RA, Wang L et al (2004) MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys 60:636–647CrossRefPubMed
7.
Zurück zum Zitat Jonsson JH, Karlsson MG, Karlsson M et al (2010) Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol 5:62–69PubMedCentralCrossRefPubMed Jonsson JH, Karlsson MG, Karlsson M et al (2010) Treatment planning using MRI data: an analysis of the dose calculation accuracy for different treatment regions. Radiat Oncol 5:62–69PubMedCentralCrossRefPubMed
8.
Zurück zum Zitat Kapanen M, Tenhunen M (2013) T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data for the pelvic bones in MRI-only based radiotherapy treatment planning. Acta Oncol 52:612–618CrossRefPubMed Kapanen M, Tenhunen M (2013) T1/T2*-weighted MRI provides clinically relevant pseudo-CT density data for the pelvic bones in MRI-only based radiotherapy treatment planning. Acta Oncol 52:612–618CrossRefPubMed
9.
Zurück zum Zitat Korhonen J, Kapanen M, Keyriläinen J et al (2014) A dual model HU conversion from MRI intensity value within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer. Med Phys 41:011704CrossRefPubMed Korhonen J, Kapanen M, Keyriläinen J et al (2014) A dual model HU conversion from MRI intensity value within and outside of bone segment for MRI-based radiotherapy treatment planning of prostate cancer. Med Phys 41:011704CrossRefPubMed
10.
Zurück zum Zitat Rasch C, Barillot I, Remeijer P et al (1999) Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43:57–66CrossRefPubMed Rasch C, Barillot I, Remeijer P et al (1999) Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 43:57–66CrossRefPubMed
11.
Zurück zum Zitat Debois M, Oyen R, Maes F et al (1999) The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45:857–865CrossRefPubMed Debois M, Oyen R, Maes F et al (1999) The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 45:857–865CrossRefPubMed
12.
Zurück zum Zitat Sannazzari GL, Ragona R, Ruo Redda MG et al (2002) CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 75:603–607CrossRefPubMed Sannazzari GL, Ragona R, Ruo Redda MG et al (2002) CT-MRI image fusion for delineation of volumes in three-dimensional conformal radiation therapy in the treatment of localized prostate cancer. Br J Radiol 75:603–607CrossRefPubMed
13.
Zurück zum Zitat Smith WL, Lewis C, Bauman G et al (2007) Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 67:1238–1247CrossRefPubMed Smith WL, Lewis C, Bauman G et al (2007) Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR. Int J Radiat Oncol Biol Phys 67:1238–1247CrossRefPubMed
14.
Zurück zum Zitat Hentschel B, Oehler W, Strauss D et al (2011) Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187:183–190CrossRefPubMed Hentschel B, Oehler W, Strauss D et al (2011) Definition of the CTV prostate in CT and MRI by using CT-MRI image fusion in IMRT planning for prostate cancer. Strahlenther Onkol 187:183–190CrossRefPubMed
15.
Zurück zum Zitat Parker C, Damyanovich A, Haycocks T et al (2003) Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66:217–224CrossRefPubMed Parker C, Damyanovich A, Haycocks T et al (2003) Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 66:217–224CrossRefPubMed
16.
Zurück zum Zitat Wachter S, Wachter-Gerstner N, Bock T et al (2002) Interobserver comparison of CT and MRI-based prostate apex definition. Clinical relevance for conformal radiotherapy treatment planning. Strahlenther Onkol 178:263–268CrossRefPubMed Wachter S, Wachter-Gerstner N, Bock T et al (2002) Interobserver comparison of CT and MRI-based prostate apex definition. Clinical relevance for conformal radiotherapy treatment planning. Strahlenther Onkol 178:263–268CrossRefPubMed
17.
Zurück zum Zitat Roberson P, McLaughlin P, Narayana V et al (2005) Use and uncertainties of mutual information for computed tomography/magnetic resonance (CT/MR) registration post permanent implant of the prostate. Med Phys 32:473–482CrossRefPubMed Roberson P, McLaughlin P, Narayana V et al (2005) Use and uncertainties of mutual information for computed tomography/magnetic resonance (CT/MR) registration post permanent implant of the prostate. Med Phys 32:473–482CrossRefPubMed
18.
Zurück zum Zitat Nyholm T, Nyberg M, Karlsson MG et al (2009) Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiat Oncol 4:54–62PubMedCentralCrossRefPubMed Nyholm T, Nyberg M, Karlsson MG et al (2009) Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiat Oncol 4:54–62PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Zhong H, Wen N, Gordon JJ et al (2015) An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy. Phys Med Biol 60:2837–2851CrossRefPubMed Zhong H, Wen N, Gordon JJ et al (2015) An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy. Phys Med Biol 60:2837–2851CrossRefPubMed
20.
Zurück zum Zitat Stanescu T, Wachowicz K, Jaffray DA (2012) Characterization of tissue magnetic susceptibility-induced distortions for MRIgRT. Med Phys 39:7185–7193CrossRefPubMed Stanescu T, Wachowicz K, Jaffray DA (2012) Characterization of tissue magnetic susceptibility-induced distortions for MRIgRT. Med Phys 39:7185–7193CrossRefPubMed
21.
Zurück zum Zitat Polat B, Guenther I, Wilbert J et al (2008) Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol 184:668–673CrossRefPubMed Polat B, Guenther I, Wilbert J et al (2008) Intra-fractional uncertainties in image-guided intensity-modulated radiotherapy (IMRT) of prostate cancer. Strahlenther Onkol 184:668–673CrossRefPubMed
22.
Zurück zum Zitat Sander L, Langkilde NC, Holmberg M et al (2014) MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol 53:809–814CrossRefPubMed Sander L, Langkilde NC, Holmberg M et al (2014) MRI target delineation may reduce long-term toxicity after prostate radiotherapy. Acta Oncol 53:809–814CrossRefPubMed
23.
Zurück zum Zitat Doemer A, Chetty IJ, Glide-Hurst C et al (2015) Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients. Radiat Oncol 10:309CrossRef Doemer A, Chetty IJ, Glide-Hurst C et al (2015) Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients. Radiat Oncol 10:309CrossRef
Metadaten
Titel
Converting from CT- to MRI-only-based target definition in radiotherapy of localized prostate cancer
A comparison between two modalities
verfasst von
Tiina Seppälä, Ph.D.
Harri Visapää, M.D.
Juhani Collan, M.D.
Mika Kapanen, Ph.D.
Annette Beule, M.D.
Mauri Kouri, M.D.
Mikko Tenhunen, Ph.D.
Kauko Saarilahti, M.D.
Publikationsdatum
01.11.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 11/2015
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-015-0868-5

Weitere Artikel der Ausgabe 11/2015

Strahlentherapie und Onkologie 11/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.